Your session is about to expire
← Back to Search
Other
Beetroot juice for Peripheral Arterial Disease
N/A
Waitlist Available
Research Sponsored by University of Nebraska
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up maximum of 30 minutes each day for 2 days
Awards & highlights
Study Summary
This trial is designed to study the effects of dietary nitrate supplementation on peripheral artery disease.
Eligible Conditions
- Peripheral Arterial Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ maximum of 14 minutes each day for 2 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~maximum of 14 minutes each day for 2 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Endothelial Function
Secondary outcome measures
Autonomic nervous system activity
Leg Blood Flow
Microvascular function
+3 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: Placebo-Beetroot juiceExperimental Treatment1 Intervention
Subjects will be tested on two different days. The first day will be a placebo and the second day will be beetroot juice. Testing will take place approximately one hour after intake. There will be a 14 day washout period between testing days.
Group II: Beetroot juice-PlaceboExperimental Treatment1 Intervention
Subjects will be tested on two different days. The first day will be beetroot juice and the second day will be a placebo. Testing will take place approximately one hour after intake. There will be a 14 day washout period between testing days.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Beetroot juice
2022
Completed Phase 4
~620
Find a Location
Who is running the clinical trial?
University of NebraskaLead Sponsor
536 Previous Clinical Trials
1,143,912 Total Patients Enrolled
11 Trials studying Peripheral Arterial Disease
494 Patients Enrolled for Peripheral Arterial Disease
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Am I eligible to participate in this scientific experiment?
"Those with peripheral arterial disease aged between 50 and 85 are suitable for this medical trial, which is currently enrolling 10 individuals."
Answered by AI
Is this clinical trial still open to potential participants?
"Clinicaltrials.gov attests that this medical study—which was inaugurated on September 5th, 2018 and updated as recently as June 9th 2022—is not currently taking in participants; however, there are 216 other trials actively enrolling at the moment."
Answered by AI
What age restrictions are in place for prospective participants of this research?
"As indicated by the requirements for enrollment, participants must be between 50 and 85 years old."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger